Catalyst Wire Dossier Catalyst Wire Dossier

DILANTIN

Phenytoin sodium, extended release · Viatris Specialty LLC
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for DILANTIN, covering 2007-08-08 to 2022-09-07. Get the full timeline:

Most recent: FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)

See pricing